The rapidly progressive neurological condition affects around 5,000 people in the UK
Category: motor neurone disease
The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
The fatal motor neurone disease currently does not have a cure available to treat patients